| P2093 | author name string | C-H Chen | |
| | C-L Lin | |
| | W-H Hsu | |
| | W-C Liao | |
| | F-C Sung | |
| | W-C Chen | |
| | C-Y Tu | |
| | C-H Li | |
| P2860 | cites work | A review of Parkinson's disease | Q22242927 |
| | Meta-analysis of early nonmotor features and risk factors for Parkinson disease | Q22252935 |
| | How common are the "common" neurologic disorders? | Q22306182 |
| | Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 |
| | Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation | Q24815148 |
| | Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort study | Q33650319 |
| | Critical threshold cerebral hypoperfusion causes Alzheimer's disease? | Q33690977 |
| | Diabetes and the risk of developing Parkinson's disease in Denmark. | Q35043736 |
| | Increased risk of chronic obstructive pulmonary disease in patients with systemic lupus erythematosus: a population-based cohort study | Q35119021 |
| | Inflammation and neurodegeneration in Parkinson's disease | Q35756452 |
| | Defect of adaptation to hypoxia in patients with COPD due to reduction of histone deacetylase 7 | Q35929930 |
| | Obesity, diabetes, and risk of Parkinson's disease | Q36769272 |
| | COPD as a systemic disease: impact on physical functional limitations | Q36901699 |
| | Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease | Q36906241 |
| | Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease | Q37431242 |
| | Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation | Q37465886 |
| | Cognitive function in COPD. | Q37722103 |
| | Epidemiology and etiology of Parkinson's disease: a review of the evidence | Q37882546 |
| | Hypoxia inducible factor-1 as a target for neurodegenerative diseases | Q37921345 |
| | Peripheral inflammatory biomarkers and risk of Parkinson's disease | Q40171172 |
| | Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study. | Q45111105 |
| | Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study | Q46514437 |
| | Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism | Q48154893 |
| | Cognitive impairment in chronic obstructive pulmonary disease--a neuropsychological and spect study | Q48364166 |
| | Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment | Q48583775 |
| | The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons | Q48753360 |
| | Mild cognitive impairment in moderate to severe COPD: a preliminary study. | Q50725504 |
| | An intact canonical NF-κB pathway is required for inflammatory gene expression in response to hypoxia. | Q52605903 |
| | Systemic Effects of Chronic Obstructive Pulmonary Disease | Q58840535 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| | chronic obstructive pulmonary disease | Q199804 |
| P304 | page(s) | 39-45 | |
| P577 | publication date | 2014-07-14 | |
| P1433 | published in | QJM: An International Journal of Medicine | Q7265477 |
| P1476 | title | The association between chronic obstructive pulmonary disease and Parkinson's disease: a nationwide population-based retrospective cohort study | |
| P478 | volume | 108 | |